A $495 million NEC verdict against Abbott in 2024 is shaking up the infant formula industry in 2025. Learn how Similac and Enfamil are linked to NEC in premature babies and what parents need to know.
In a major legal decision, a Missouri jury awarded $495 million to a family who said their premature baby developed NEC (Necrotizing Enterocolitis) after being fed Similac formula. This case has caught national attention and is now affecting the whole infant formula industry in 2025.
What is NEC?
NEC is a serious stomach disease (a serious gastrointestinal illness) that mostly affects premature babies. It can cause infections, damage to the intestines, and even death. Doctors have found that premature babies fed cow’s milk-based formula, like Similac and Enfamil, have a higher risk of developing NEC than those fed breast milk.
⚖️ Why Was Abbott Ordered to Pay?
In this case, the jury said Abbott Laboratories, the company that makes Similac, didn’t warn parents or hospitals about the NEC risks. The family received:
- $95 million in medical costs and damages
- $400 million in punishment against Abbott
This large amount shows how serious the jury thought the problem was.
More Lawsuits Are Coming
After this verdict, hundreds of families have filed lawsuits across the U.S. These cases have been grouped into one large case called an MDL (Multidistrict Litigation). Judges are now allowing experts to testify that formulas can cause NEC, making it easier for more families to join the lawsuits.
What Should Parents Know?
If your baby was born early and developed NEC after drinking Similac or Enfamil:
- You may be able to join one of these lawsuits.
- A lawyer can help you understand if you qualify for compensation.
- These cases may cover medical bills, suffering, and more.
Final Thoughts
This $495 million verdict has made the public more aware of what’s in baby formula and how it can affect newborns—especially premature babies. More changes in labeling, safety, and legal rules may come in the future.
If you’re affected, schedule a free consultation now. Join our Community Forum to connect and act.
Comments are closed